Biocompatible dual drug formulation of resveratrol and hydroxychloroquine for targeted liver cancer: in vitro HepG2 model anti-hepatocellular carcinoma and in vivo safety assessments
Hepatocellular carcinoma (HCC) is one of the most aggressive cancers with limited therapeutic efficacy and high drug resistance. This study developed a biocompatible dual-drug delivery system based on layer-by-layer liquid crystalline nanoparticles (LbL-LCNPs) co-loaded with resveratrol (RES) and hydroxychloroquine (...